What is ImmunityBio, Inc.'s earnings yield?

ImmunityBio, Inc. (IBRX) reported earnings yield of -10.8% in Q1 2026.

How has ImmunityBio, Inc.'s earnings yield changed year-over-year?

ImmunityBio, Inc.'s earnings yield increased by 32.3% year-over-year, from -15.9% to -10.8%.

What is the long-term trend for ImmunityBio, Inc.'s earnings yield?

Over 5 years (2020 to 2025), ImmunityBio, Inc.'s earnings yield has grown at a 37.6% compound annual growth rate (CAGR), from -3.6% to -18%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

ImmunityBio, Inc. IBRX Earnings yield

Earnings yield at other companies

Bristol-Myers SquibbBMY

5.9%+1.6pp

Johnson & JohnsonJNJ

3.6%-1.9pp

Merck & Co.MRK

3%-4.7pp

Gilead SciencesGILD

5.3%+1.1pp

Immunovant, Inc.IMVT

-10%-2.3pp

Kymera TherapeuticsKYMR

-4.6%-1.8pp

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Calculated from ImmunityBio, Inc.’s reported figures.

net income/market cap=-10.8%

Based on trailing twelve months.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s earnings yield?: ImmunityBio, Inc. (IBRX) reported earnings yield of -10.8% in Q1 2026.
How has ImmunityBio, Inc.'s earnings yield changed year-over-year?: ImmunityBio, Inc.'s earnings yield increased by 32.3% year-over-year, from -15.9% to -10.8%.
What is the long-term trend for ImmunityBio, Inc.'s earnings yield?: Over 5 years (2020 to 2025), ImmunityBio, Inc.'s earnings yield has grown at a 37.6% compound annual growth rate (CAGR), from -3.6% to -18%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.